Anti-HGFR / c-Met Reference Antibody (Metheresis patent anti-Met)

Used in targeted cancer therapies, particularly for tumors with c-Met receptor overexpression or dysregulation, such as non-small cell lung cancer, hepatocellular carcinoma, and gastric cancers. This antibody blocks hepatocyte growth factor (HGF)-mediated signaling through the c-Met pathway, inhibiting tumor cell proliferation, survival, migration, and invasion. It is employed in research and therapeutic development to study metastasis and angiogenesis, and serves as a reference in the design of biosimilars or novel anti-Met antibodies. Its high specificity makes it valuable in diagnostic assays and preclinical testing of combination therapies involving c-Met inhibition.

Mechanism	-
Appearance	-
Longevity	-
Strength	-
Storage	-
Shelf Life	-
Allergen(s)	-
Dosage (Range)	-
Recommended Dosage	-
Dosage (Per Day)	-
Recommended Dosage (Per Day)	-
Mix Method	-
Heat Resistance	-
Stable in pH range	-
Solubility	-
Product Types	-
INCI	-